Your session is about to expire
← Back to Search
Telehealth Palliative Care for Dementia (IBC Trial)
N/A
Waitlist Available
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
IBC Trial Summary
This trial will test a new telehealth care model to see if it improves outcomes for people with dementia and their caregivers.
Who is the study for?
This trial is for adults over 18 with Alzheimer's or related dementias who have seen a Jefferson PCP in the last three years. Participants need access to telehealth technology and must speak English. It excludes those with traumatic brain injuries, current incarceration, homelessness, active antipsychotic medication use, or pregnancy.Check my eligibility
What is being tested?
The study tests a Telehealth Integrated Primary Care (TIPC) model developed for dementia patients during COVID-19. Over 12 months, it will assess patient outcomes, engagement with support services, advanced care planning activities and healthcare utilization patterns.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention focusing on telehealth services rather than drugs or medical procedures, traditional side effects are not applicable. However, participants may experience issues related to the usability of technology or stress associated with adapting to new forms of communication.
IBC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Caregiver Support/Burden
Change in Decision-Making
Change in Disease-Related Quality of Life
+1 moreSecondary outcome measures
Interventional procedure
IBC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Individuals in the intervention group will undergo a series of two telehealth video visits and a series of survey assessments at baseline, 3, 6, 9, and 12 months.
Group II: ControlActive Control1 Intervention
Individuals in the control group will continue with their usual standard of care and undergo a series of survey assessments at baseline, 3, 6, 9 and 12 months.
Find a Location
Who is running the clinical trial?
Independence Blue CrossUNKNOWN
6 Previous Clinical Trials
126,487 Total Patients Enrolled
Thomas Jefferson UniversityLead Sponsor
445 Previous Clinical Trials
145,664 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English.I am over 18 years old.I have had a traumatic brain injury.I have been diagnosed with Alzheimer's or a related dementia, or have been treated for cognitive impairment in the last 3 years and have a Jefferson PCP.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are actively engaged in the research?
"Affirmative. According to data available on clinicaltrials.gov, the medical trial is actively seeking participants since its initiation on June 29th 2022 and most recent update on September 6th 2022. 50 patients must be enrolled at one site for this project to move forward successfully."
Answered by AI
Are there any unfilled vacancies in this clinical trial at present?
"This clinical trial is actively seeking patients, with the initial post date of June 29th 2022 and last update on September 6th 2022. This information can be found by searching for it on clinicaltrials.gov."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger